Assessing the impact of socioeconomic and regional inequalities on surgical treatment for kidney cancer.
“Closure” nephrectomy after response to immunotherapy: Clinical, molecular, and tumor microenvironment characterization
Search for a proteomic signature predictive of response to first-line treatments in metastatic kidney cancer
Search for a prognostic proteomic signature of relapse in patients with clear cell renal cell carcinoma who relapse within 18 months post-surgery
